Stay updated on AMX0035 in ALS: Phoenix Clinical Trial
Sign up to get notified when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.

Latest updates to the AMX0035 in ALS: Phoenix Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange Detected- Added a government operations notice and operating details, plus a new v3.2.0 revision. - Removed the previous v3.1.0 revision.SummaryDifference3%
- Check21 days agoChange DetectedVersion update to v3.1.0 accompanies removal of several drug-safety topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and no new substantive topics added.SummaryDifference0.4%
- Check29 days agoNo Change Detected
- Check36 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No other content changes.SummaryDifference0.2%
- Check43 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.SummaryDifference0.2%
- Check50 days agoChange DetectedThe web page has been updated to include new drug information and resources related to Sodium Phenylbutyrate and Amyotrophic Lateral Sclerosis, while also changing the facility name and location details.SummaryDifference3%
- Check64 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to AMX0035 in ALS: Phoenix Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AMX0035 in ALS: Phoenix Clinical Trial page.